Skånland SS, Mato AR(2021) Overcoming resistance to targeted therapies in chronic lymphocytic leukemia Blood Adv, 5(1), 334-343 DOI 10.1182/bloodadvances.2020003423, PubMed 33570649
Mato AR, Roeker LE, Lamanna N, Allan JN, Leslie L, Pagel JM, Patel K, Osterborg A, Wojenski D, Kamdar M, Huntington SF, Davids MS, Brown JR, Antic D, Jacobs R, Ahn IE, Pu J, Isaac KM, Barr PM, Ujjani CS, Geyer MB, Berman E, Zelenetz AD, Malakhov N, Furman RRet al.(2020) Outcomes of COVID-19 in patients with CLL: a multicenter international experience Blood, 136(10), 1134-1143 DOI 10.1182/blood.2020006965, PubMed 32688395
Skånland SS, Karlsen L, Taskén K(2020) B cell signalling pathways-New targets for precision medicine in chronic lymphocytic leukaemia Scand J Immunol, 92(5), e12931 DOI 10.1111/sji.12931, PubMed 32640099